These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15231680)

  • 21. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
    Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
    Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M
    Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.
    Sieuwerts AM; Meijer-van Gelder ME; Timmermans M; Trapman AM; Garcia RR; Arnold M; Goedheer AJ; Portengen H; Klijn JG; Foekens JA
    Clin Cancer Res; 2005 Oct; 11(20):7311-21. PubMed ID: 16243802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
    Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H
    Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of estrogen receptor alpha and progesterone receptor in normal human breast epithelium.
    Umekita Y; Souda M; Ohi Y; Rai Y; Sagara Y; Sagara Y; Yoshida H
    In Vivo; 2007; 21(3):535-9. PubMed ID: 17591366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer.
    Auer D; Reimer D; Porto V; Fleischer M; Roessler J; Wiedemair A; Marth C; Müller-Holzner E; Daxenbichler G; Zeimet AG
    Breast Cancer Res Treat; 2009 Jul; 116(1):103-11. PubMed ID: 18618240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor alpha and beta profiling in human breast cancer.
    Balfe P; McCann A; McGoldrick A; McAllister K; Kennedy M; Dervan P; Kerin MJ
    Eur J Surg Oncol; 2004 Jun; 30(5):469-74. PubMed ID: 15135471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
    Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S
    Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of GATA3 expression in breast cancer: a 10-year follow-up study.
    Ciocca V; Daskalakis C; Ciocca RM; Ruiz-Orrico A; Palazzo JP
    Hum Pathol; 2009 Apr; 40(4):489-95. PubMed ID: 19084267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of the expression of ERRalpha as a potential biomarker in breast cancer.
    Jarzabek K; Koda M; Kozlowski L; Sulkowski S; Kottler ML; Wolczynski S
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):127-33. PubMed ID: 19138740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.
    Rokavec M; Schroth W; Amaral SM; Fritz P; Antoniadou L; Glavac D; Simon W; Schwab M; Eichelbaum M; Brauch H
    Cancer Res; 2008 Dec; 68(23):9799-808. PubMed ID: 19047159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis.
    Nagasaki S; Suzuki T; Miki Y; Akahira J; Kitada K; Ishida T; Handa H; Ohuchi N; Sasano H
    Cancer Res; 2009 Feb; 69(4):1392-9. PubMed ID: 19190350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
    Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
    Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H
    Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1.
    Rody A; Holtrich U; Gaetje R; Gehrmann M; Engels K; von Minckwitz G; Loibl S; Diallo-Danebrock R; Ruckhäberle E; Metzler D; Ahr A; Solbach C; Karn T; Kaufmann M
    Clin Cancer Res; 2007 Feb; 13(4):1115-22. PubMed ID: 17317819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
    Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
    Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Function of estrogen-related receptor alpha in human endometrial cancer.
    Watanabe A; Kinoshita Y; Hosokawa K; Mori T; Yamaguchi T; Honjo H
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1573-7. PubMed ID: 16464951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.